A class-action lawsuit against a Moncton-based medical cannabis producer has been given the green light to proceed to trial, according to Halifax-based law firm Wagners.
Wagners says a Nova Scotia Supreme Court judge released a decision on Jan. 18 to certify the action against OrganiGram.
The lawsuit stems from two recalls in late 2016 and early 2017 of OrganiGram cannabis that was produced between Feb. 1 and Dec. 16, 2016. Products allegedly tested positive for myclobutanil or bifenazate, which are both unauthorized pesticides.
Wagners, which is acting on behalf of those who bought the recalled product, says it has received reports of clients experiencing negative health effects. The law firm also says clients want to be refunded the money they spent on the recalled products because those items failed to meet their expectation of regulatory compliance.
- RCMP cannabis raids won’t ‘hamper’ N.B. First Nations pot sale discussions: minister
- Quebec cannabis use is dropping, but how much depends on age range
- First Nation blocks main highway to Halifax over cannabis crackdown
- N.S. First Nation tells government and RCMP to stay out of cannabis and tobacco sales
-
![]()
Province considers safety changes at cannabis stores -
![]()
Health Matters: Talking to teens about the risks of cannabis poisoning -
![]()
Atlantic Mi’kmaq communities at odds with Nova Scotia government over cannabis -
![]()
N.S. Premier Tim Houston responds to tensions between RCMP and First Nations following recent cannabis raid
Certification is the first step in a class action. Class-action lawsuits can only go ahead with a trial if they have been certified.
OrganiGram has said it will aggressively defend itself against the lawsuit.
Comments
Want to discuss? Please read our Commenting Policy first.